ArticleGland surgery2020
A rare case showing an enlarged level I lymph node as the first symptom due to papillary thyroid microcarcinoma.
Article in Gland surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As the high-pace development of sonography in recent years, the incidence of papillary thyroid carcinoma (PTC) has increased sharply worldwide, especially papillary thyroid microcarcinoma (PTMC). As we all know, PTMC is an indolent tumor, and level I lymph nodes (LNs) at a higher region relatively, so the majority of PTMCs admitted to surgery before the level I LNs metastasis. It is rare to see PTMC with level I LNs metastasis. At best of our known, there is only one Chinese research mentioned it but without a description of it. In this case, we reported a 30-year-old female who developed a recurrent submental cystic mass after being received treatment to remove a certain volume of light-yellow fluid. Pathology verified that mass in the submental area involved by PTMC. We consider that it may relate to age, multifocality, the diameter of PTMC, numbers of central compartment LNs, and "re-metastasis".
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.